Skip to content

A Blog by Biocon

'BioConversations'

  • Home
  • About Us
  • Healthcare
  • Innovation
  • Policy
  • Biosimilars
  • Disease Epidemiology
  • Comments Policy
  • Contact

Month: October 2016

#DetectToDefeat – Battle Cry in Breast Cancer Crusade

Breast cancer is the second most common cancer in the world and, by far, the most frequent cancer among women. Every 19 seconds someone is diagnosed with breast cancer and every 74 seconds someone dies from it!

‘Stand-out’ Quarter for Biocon’s Biologics Business

Biocon reported strong Q2FY17 results. Small Molecules, Biologics and Research Services businesses showed strong growth while it was a stand-out quarter for the Biologics business.

Realizing the Promise of Biosimilars in 2020

Part 2 – The potential financial benefits and better health outcomes from biosimilars use could spur their uptake in health systems globally.

Antimicrobial Resistance (AMR) – A global threat is here to stay!

Antimicrobial resistance (AMR) represents a global catastrophe that threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.

Follow us on Twitter

My Tweets

Like us on Facebook

Like us on Facebook

Biocon Limited

20th KM, Hosur Road,
Electronic City,
Bangalore, India - 560 100
Email: contact.us@biocon.com
+91 80 2808 2808 / 91 80 4014 4014

Search

Social

  • View bioconlimited’s profile on Facebook
  • View Bioconlimited’s profile on Twitter
  • View bioconlimited’s profile on YouTube

Archives

  • April 2018
  • March 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • July 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016

DISCLAIMER

Please read our Disclaimer and Comments Policy before engaging on our blog!

Create a website or blog at WordPress.com